Heart Failure Drug a New Treatment Option for Alcoholism? Heart Failure Drug a New Treatment Option for Alcoholism?
Spironolactone, a potassium-sparing diuretic typically used to treat heart failure and hypertension, has shown promise for alcohol use disorder, a common condition with few treatment options.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 27, 2022 Category: Psychiatry Tags: Psychiatry News Source Type: news

Arthritis: Four fruits full of potassium that could protect joints - expert
Potassium-rich foods can help protect bones and joints, which is vital when it comes to treating symptoms of arthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - September 26, 2022 Category: Consumer Health News Source Type: news

Efficacy and Safety of Keverprazan for Erosive Esophagitis Efficacy and Safety of Keverprazan for Erosive Esophagitis
In this study, keverprazan, a novel potassium-competitive acid blocker, showed comparable safety and efficacy to lansoprazole in treating erosive esophagitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2022 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Diet changes may help head off kidney stone recurrence
People with lower levels of dietary calcium and potassium were more likely to have a follow-up episode of kidney stones than were those whose diets included more of those minerals. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 13, 2022 Category: Consumer Health News Authors: Linda Searing Source Type: news

Lupin gets US FDA approval for generic used to cleanse colon
US FDA's approval is for sodium sulfate, potassium sulfate and magnesium sulfate oral solution of strength 17.5 g/3.13 g/1.6 g per 6 ounces, Lupin said in a stock exchange filing. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution had estimated annual sales of USD 202 million in the U.S., it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 9, 2022 Category: Pharmaceuticals Source Type: news

Webb Space Telescope Expected to Reveal a New Exoplanet Photo
At some point things were destined to settle down in the glassed-in mission control room at the Space Telescope Science Institute (STScI) in Baltimore, Md. For much of this year, the Institute has been the center of the astronomical world. After all, it is there that each image captured by the new James Webb Space Telescope first arrives, including the dazzling batch received and released in July. But the real work the Institute team does—analyzing the scientific data embedded in the pictures— is quieter, less flashy stuff. Still, this week, as NASA reports, that quiet was broken by a new analysis of one of th...
Source: TIME: Science - August 26, 2022 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized healthscienceclimate Space Source Type: news

Thinking Like a Tree – A Tribute to Life Sustainers
By Jan LundiusSTOCKHOLM, Aug 24 2022 (IPS) When I was a child, a friend asked me: “How would you describe a tree to someone who has never seen one?” I looked at the trees surrounding us and realised it was impossible, considering their versatility, beauty and utter strangeness. Since that time, I have often wondered about trees, as well as I have been worried by the indiscriminate destruction of trees and forests. Trees are a prerequisite for life and intimately connected with humans’ existence. In these times of climate change, many of us are becoming increasingly aware of the life-promoting function of trees. How ...
Source: IPS Inter Press Service - Health - August 24, 2022 Category: International Medicine & Public Health Authors: Jan Lundius Tags: Climate Change Environment Food and Agriculture Global Headlines Health Sustainability TerraViva United Nations Water & Sanitation IPS UN Bureau Source Type: news

Aug 12 2022 This Week in Cardiology Aug 12 2022 This Week in Cardiology
AF screening; sodium, potassium, BP, and CV outcomes; drug prices; and cardio-respiratory fitness are the topics John Mandrola, MD, covers in this week ’s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 12, 2022 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Low Dietary Calcium, Potassium Intake Tied to Kidney Stone Recurrence
FRIDAY, Aug. 12, 2022 -- Lower dietary calcium and potassium intake are risk factors for symptomatic kidney stone recurrence, according to a study published in the August issue of the Mayo Clinic Proceedings. Api Chewcharat, M.D., from the Mayo... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2022 Category: Pharmaceuticals Source Type: news

8/10 --A Switch to Salt Substitute Could Slash Your Heart Risks
WEDNESDAY, Aug. 10, 2022 -- Swapping salt out for the salt substitute potassium chloride lowers blood pressure, and thereby the risk of heart attack, stroke and cardiovascular disease, a new analysis finds. " It ' s in processed and prepared foods... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2022 Category: General Medicine Source Type: news

Low Calcium, Potassium Key Risk Factors for Kidney Stones Low Calcium, Potassium Key Risk Factors for Kidney Stones
Low dietary calcium and potassium intake are key risk factors for the development and recurrence of symptomatic kidney stones.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 1, 2022 Category: Consumer Health News Tags: Nephrology News Source Type: news

Pfizerpen (Penicillin G potassium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 1, 2022 Category: Drugs & Pharmacology Source Type: news

Diets higher in calcium and potassium may help prevent recurrent symptomatic kidney stones, Mayo Clinic study finds
ROCHESTER, Minn. —­ Kidney stones can cause not only excruciating pain but also are associated with chronic kidney disease, osteoporosis and cardiovascular disease. If you've experienced a kidney stone once, you have a 30% chance of having another kidney stone within five years. Changes in diet are often prescrib ed to prevent recurrent symptomatic kidney stones. However, little research is available regarding dietary changes for those who have one incident of kidney stone formation versus those… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 1, 2022 Category: Databases & Libraries Source Type: news

Links Between Potassium Intake, BP, and CVD Events Differ by Sex
TUESDAY, July 26, 2022 -- Women with a high sodium intake appear to benefit most from higher potassium intake with respect to systolic blood pressure (SBP), according to a study published online July 21 in the European Heart Journal. Rosa D. Wouda,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 26, 2022 Category: Pharmaceuticals Source Type: news

Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT ® and Lazertinib Combination for Patients with Non-Small Cell Lung Cancer and EGFR Mutations
July 26, 2022 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 1b/2 CHRYSALIS-2 study (NCT04077463) cohort evaluating the safety and tolerability of the combination of RYBREVANT® (amivantamab-vmjw) with the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) lazertinib and platinum-based chemotherapy (carboplatin and pemetrexed) in patients with relapsed/refractory non-small cell lung cancer (NSCLC) and EGFR mutations.[1] These findings and additional updates, including data on RYBREVANT® in combination with laze...
Source: Johnson and Johnson - July 26, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news